Patent · US Active

LFA-1 inhibitor and methods of preparation and polymorph thereof

US10906892B2 · kind B2 · utility

0Cited by

65References

15Claims

0Family size

Assignee

Novartis Pharmaceuticals Corporation · US

Inventors

James Robert Zeller · Holland, US
Sripathy Venkatraman · Slingerlands, US
Elisabeth C. A. Brot · Albany, US
Subashree Iyer · Guilderland, US
Michael Hall · Albany, US

Key dates

Filing date	Jan 15, 2019
Grant date	Feb 2, 2021
Priority date	—
Expiry date	Jan 15, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of preparation and purification of a compound of Formula I, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.